DAVIGNON ETIENNE 4
4 · GILEAD SCIENCES INC · Filed May 15, 2012
Insider Transaction Report
Form 4
DAVIGNON ETIENNE
Director
Transactions
- Exercise/Conversion
Common Stock
2012-05-12+3,632→ 604,023 total - Tax Payment
Common Stock
2012-05-12$51.84/sh−1,089$56,454→ 602,934 total - Exercise/Conversion
Restricted Stock Units
2012-05-12−3,632→ 2,926 total→ Common Stock (3,632 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]100% of the restricted stock units vested on May 12, 2012, at the end of the first year of service.